Comprehensive Tumor Genomic Profiling Panel (526 Genes, SNVs, Indels, Fusions, TMB, MSI) in UAE | 12,000 AED

Executive Summary & Core Metrics

Advanced genomic profiling of 526 cancer-relevant genes detecting single nucleotide variants (SNVs), small insertions/deletions (indels), gene fusions, tumor mutational burden (TMB), and microsatellite instability (MSI). Delivered with 99.9% diagnostic sensitivity from an ISO 15189:2012 accredited laboratory, secure courier solid tissue specimen retrieval, and telephonic clinical guidance by a DHA-licensed specialist.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval with ISO-certified cold-chain handling.
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by a DHA-licensed specialist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Price: 12,000 AED (inclusive of comprehensive analysis and clinical reporting).

Test Overview & Methodology

The Comprehensive Tumor Genomic Profiling Panel combines next-generation sequencing (NGS) analysis of 526 cancer-relevant genes with tumor mutational burden (TMB) and microsatellite instability (MSI) assessment, delivering actionable insights for personalized oncology. This test is performed on FFPE tumor tissue and provides a complete genomic landscape to guide targeted therapy, immunotherapy, and clinical trial options.

Feature	Our Test – UAE Gold Standard	Closest Alternative
Gene Coverage	526 genes (full coding regions)	<50 hotspot regions
Alterations Detected	SNVs, Indels, Fusions, TMB, MSI	SNVs only, no TMB/MSI
Methodology	Next‑Generation Sequencing (NGS), ISO‑certified laboratory	PCR‑based limited genotyping
Turnaround Time	4 weeks (rigorous bioinformatics & expert review)	2–3 weeks (automated only)

Physician Insight & Safety Protocols

Physician Clinical Insight

“As a specialist in diagnostic radiology, I recommend this comprehensive panel for patients with advanced or rare cancers when standard therapies have failed. Genomic findings must always be correlated with clinical and radiological data for optimal treatment planning. Do not discontinue prescribed medication without consulting your doctor.”

— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011

Exclusion Criteria & Red Flags

Test not indicated without a confirmed cancer diagnosis or valid clinical suspicion.
Insufficient FFPE tissue (tumor content <20%) may lead to inconclusive results.
Seek immediate medical attention if you experience severe pain, bleeding, swelling, or signs of infection at the biopsy site.
This test is performed under the provisions of Federal Decree-Law No. 4 of 2016 on Medical Liability. All genomic data is processed and stored in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Patient FAQ & Clinical Guidance

What is the turnaround time for the Comprehensive Tumor Panel?

Results are typically delivered within 4 weeks from receipt of the FFPE tissue block, encompassing comprehensive sequencing and expert oncologist validation. This timeline ensures rigorous quality control, advanced bioinformatics analysis, and a detailed clinical report with therapeutic implications. In some cases, retesting of borderline samples may extend the period, and our support team will communicate any delays proactively.

Is this covered by UAE medical insurance?

Most major UAE insurers cover comprehensive genomic profiling when prescribed for an approved oncology indication, and our team verifies benefits before collection. We provide direct billing verification via WhatsApp at +971 54 548 8731, ensuring transparency and minimizing out-of-pocket costs. Always confirm your policy’s genetic testing clause, as coverage depends on the specific clinical scenario and insurer guidelines.

How is my sample handled and is my genomic data kept confidential?

Your FFPE block is transported under ISO-certified cold-chain conditions via secure medical courier, and all genomic data is encrypted and strictly protected under UAE PDPL (Federal Decree-Law No. 45 of 2021 on Personal Data Protection) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Only authorized laboratory personnel process the sample, and results are shared exclusively with your ordering physician through a secure portal. We never store identifiable data longer than necessary and comply fully with Federal Decree-Law No. 4 of 2016 on Medical Liability for clinical safety.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is encrypted, processed under stringent security protocols, and shared exclusively with the referring DHA-licensed physician. Your privacy and data security are our highest priorities, and we maintain full compliance with all UAE health data protection frameworks.

Clinical & Logistical Metadata

Test Name	Comprehensive Tumor Genomic Profiling Panel (526 Genes, SNVs, Indels, Fusions, TMB, MSI)
Price (AED)	12,000 AED (Inclusive of all taxes & clinical reporting)
Turnaround Time	4 weeks from receipt of FFPE tissue block
Sample Type / Matrix	Archival FFPE Tumor Tissue Block (Solid Tissue Specimen)
Methodology Used	Next-Generation Sequencing (NGS) – ISO 15189:2012 Accredited
ICD-10-CM Code	C80.1 (Malignant neoplasm without specification of site)
LOINC Code	61313-1 (Comprehensive genomic profiling panel)
DHA Facility License & Laboratory Address Invariants	DHA License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE